JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoetzenecker, K.
Right arrow Articles by Lang, I. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hoetzenecker, K.
Right arrow Articles by Lang, I. M.
Related Collections
Right arrow Congenital - acyanotic
Right arrowRelated Article

J Thorac Cardiovasc Surg 2009;138:786
© 2009 The American Association for Thoracic Surgery

Letter to the Editor

Reply to the Editor

Konrad Hoetzenecker, MDa, Hendrik J. Ankersmit, MDa, Irene M. Lang, MDb

a Department of Cardiothoracic Surgery, Medical University of Vienna, Austria
b Department of Cardiology, Medical University of Vienna, Austria

The first 20% of the full text of this article appears below.

We thank Dr Beghetti and colleagues for their thoughtful comments regarding the hemodynamic evaluation and further management of our recent case of atrial septal defect (ASD).1Go The management of patients with a degree of pulmonary vascular disease prior to shunt closure has been a matter of debate. In addition, recent studies demonstrating the efficacy of oral vasodilators in pulmonary vascular disease associated with congenital systemic-to-pulmonary shunts2,3Go have fueled an uncertainty of vasodilator pretreatments prior to shunt closure.

Despite optimized medical treatment with diuretics, antibiotics, and oral anticoagulant over 4 months since the first . . . [Full Text of this Article]


Related Article

Pulmonary arterial hypertension and congenital heart disease: Targeted therapies and operability
Maurice Beghetti and Cecile Tissot
J. Thorac. Cardiovasc. Surg. 2009 138: 785-786. [Extract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.